Table 3.
Drug | Gene | Disease/model | Method | Main effects | Reference |
---|---|---|---|---|---|
Lithium | 5mC and 5hmC | Rat primary cortical neurons | Immunocytochemis try | Prevention of rotenone-induced increase in DNA methylation. | Scola et al., 2014 |
Lithium | BDNF | PBMCs from BD patients | MSP | Reduction of BDNF methylation. | D’Addario et al., 2012 |
Lithium | BDNF | PBMCs from BD patients | MSP | Reduction of BDNF methylation. | Dell’Osso et al., 2014 |
Lithium | Bdnf | Rat hippocampal neurons | MSP | Hypomethylation of Bdnf exon IV promoter. | Dwivedi and Zhang, 2014 |
Lithium | Genome-wide methylation | SK-N-SH cells | Infinium HumanMethylation 27 | Hypermethylation of 345 genes and hypomethylation of 138 genes. | Asai et al., 2013 |
Lithium | Global methylation | Lymphoblasts from BD patients | ELISA | No effect on global methylation in patients (it remained decreased compared to controls after treatment). Rescue of methylation levels in relatives. | Huzayyin et al., 2014 |
Lithium | Igf2, Igf2r, H19 | Mouse ESCs | Bisulfite sequencing | Hypomethylation of imprinted control regions via Dnmr3a2. | Popkie et al., 2010 |
Valproate | BDNF | PBMCs from BD patients | MSP | Reduction of BDNF methylation. | D’Addario et al., 2012 |
Valproate | BDNF | PBMCs from BD patients | MSP | Reduction of BDNF methylation. | Dell’Osso et al., 2014 |
Valproate | Genome-wide methylation | SK-N-SH cells | Infinium HumanMethylation 27 | Hypermethylation of 64 genes and hypomethylation of 36 genes. | Asai et al., 2013 |
Valproate | Global methylation | Primary rat astreocyte | LUMA | Global hypomethylation. | Perisic et al., 2010 |
Valproate | Glt-1 | Primary rat cortical astrocyte | Bisulfite sequencing | Demethylation of Glt-1 promoter. | Perisic et al., 2010 |
Valproate | p21 | Mouse hippocampal cells | PCR and restriction enzymes analysis | Demethylation of the distal region of p21. | Aizawa and Yamamuro, 2015 |
Valproate | RELN | Mouse striatum (frontal cortex) | 5-methyl CpG ChIP | Decrease of RELN methylation after treatment to increase DNMT activity. | Dong et al., 2008 |
Carbamazepine | Genome-wide methylation | SK-N-SH cells | Infinium HumanMethylation 27 | Hypermethylation of 64 genes and hypomethylation of 14 genes. | Asai et al., 2013 |
Lamotrigine | Global methylation | Primary rat cortical astrocyte | LUMA | No changes in DNA methylation. | Perisic et al., |
BD – bipolar disorder; Igf2 - insulin-like growth factor 2; Igf2r - insulin-like growth factor 2 receptor; HTR2A – serotonin receptor 2A; BDNF – brain-derived neurotrophic factor; 5mC – 5-methylcytosine; 5-hmC – 5-hydroxymethylcytosine; SLC6A4 - solute carrier family 6 (neurotransmitter transporter, serotonin) member 4; RELN - reelin; Glt-1 - glutamate type I transporter; LUMA - luminometric methylation analysis; MSP – methylation-specific PCR; PBMC – peripheral blood mononuclear cells; ChIP – chromatin immunoprecipitation.